Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00735215 | Faslodex Registry: Fulvestrant in Current Clinical Practice | completed | — | 200 | AstraZenecaINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00706069 | Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer | completed | Phase 1 | 40 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00174707 |
| Study of Docetaxel in Breast Cancer Patients |
| completed |
| Phase 3 |
| 998 |
| SanofiINDUSTRY |
| 1 |
| Dec 7, 2009 |
| clinicaltrials |
| NCT01025349 | Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer | completed | Phase 2 | 20 | Taipei Medical University HospitalOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients | completed | Phase 1 / Phase 2 | 103 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 20, 2009 | clinicaltrials |
| NCT00191451 | A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer | completed | Phase 2 | 150 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00237224 | Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole | completed | Phase 4 | 40 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00333047 | Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy | completed | Phase 2 / Phase 3 | 24 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT01016665 | Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy | completed | N/A | 71 | Federal University of São PauloOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00608452 | Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers | completed | — | 121 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00191815 | Combination Chemotherapy for Metastatic Breast Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 11, 2009 | clinicaltrials |
| NCT00996632 | The Use of a High-frequency Ultrasonic Knife in Breast Cancer Surgery(UKBC) | completed | N/A | 94 | University of TriesteOTHER | 1 | Nov 11, 2009 | clinicaltrials |
| NCT00146549 | Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer | completed | Phase 3 | 250 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00750464 | Collection of Raw Data of Thermal Imaging for the Purpose of Developing a Device for Early Detection of Breast Cancer | completed | — | 575 | Real Imaging Ltd.INDUSTRY | 1 | Oct 14, 2009 | clinicaltrials |
| NCT00830973 | The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer(MHSLabCorp1) | completed | — | 184 | Medco Health Solutions, Inc.INDUSTRY | 1 | Oct 14, 2009 | clinicaltrials |
| NCT00431106 | Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer | completed | Phase 3 | 144 | Hellenic Oncology Research GroupOTHER | 1 | Sep 28, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00617968 | GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer | completed | Phase 2 | 5 | SanofiINDUSTRY | 1 | Sep 2, 2009 | clinicaltrials |
| NCT00002679 | Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer | completed | Phase 2 | 89 | Yale UniversityOTHER | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00080743 | Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer | completed | Phase 2 | 2 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | completed | Phase 2 | 250 | Hospital San Carlos, MadridOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00169000 | Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers | completed | Phase 1 | 12 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00156039 | Randomized Trial of Follow-up Strategies in Breast Cancer | completed | Phase 4 | 968 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jul 28, 2009 | clinicaltrials |
| NCT00582322 | Genetic Studies in Breast Cancer | completed | — | 483 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 20, 2009 | clinicaltrials |
| NCT00759837 | Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects | completed | Phase 1 | 27 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 16, 2009 | clinicaltrials |
| NCT00638599 | Comparison of Laryngeal Mask Airway (LMA®) and Tracheal Tube in Modified Radical Mastectomy on Breast Cancer(LMATBBC) | completed | Phase 4 | 200 | Nanjing Medical UniversityOTHER | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00940199 | PASSION - P Trial: Ph Adjusted Sulfur-Colloid, Sentinel Initiative ON Pain Trial(PassionP) | completed | — | 140 | Walter Reed Army Medical CenterFED | 1 | Jul 15, 2009 | clinicaltrials |
| NCT00582803 | Adherence to Intensive Surveillance for Hereditary Breast Cancer | completed | — | 85 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00824876 | Orthostatic Tolerance in Mamma Cancer Patients After Anaesthesia | completed | — | — | Rigshospitalet, DenmarkOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00606931 | Pilot Study to Evaluate High Resolution PET Image-Guidance for Sampling of Breast Abnormalities(PEM-BX) | completed | N/A | 22 | Naviscan PET SystemsINDUSTRY | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | completed | Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00919399 | Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant(TAMARO) | completed | Phase 2 | 15 | Institut Claudius RegaudOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00287534 | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.(ARNO-95) | completed | Phase 2 | 1,059 | AstraZenecaINDUSTRY | 1 | Jun 9, 2009 | clinicaltrials |
| NCT00096668 | Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer | completed | Phase 2 | 47 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00385177 | Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors | completed | Phase 1 | 61 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00306631 | A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1 | completed | Phase 2 | 65 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | completed | Phase 2 | 73 | Eli Lilly and CompanyINDUSTRY | 2 | May 29, 2009 | clinicaltrials |
| NCT00429871 | Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer | completed | Phase 3 | 272 | Hellenic Oncology Research GroupOTHER | 1 | May 29, 2009 | clinicaltrials |
| NCT00909649 | Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy(MRM) | completed | N/A | 50 | Mansoura UniversityOTHER | 1 | May 28, 2009 | clinicaltrials |
| NCT00784862 | ATAC - Pharmacokinetics (PK) Sub-Protocol | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | May 15, 2009 | clinicaltrials |
| NCT00193908 | Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream | completed | Phase 3 | 333 | Trans Tasman Radiation Oncology GroupOTHER | 1 | May 14, 2009 | clinicaltrials |
| NCT00036023 | Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies | completed | Phase 2 | — | AmgenINDUSTRY | 0 | May 11, 2009 | clinicaltrials |
| NCT00087958 | Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment | completed | Phase 2 | 168 | SanofiINDUSTRY | 15 | May 1, 2009 | clinicaltrials |
| NCT00286117 | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years | completed | Phase 3 | 448 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00300508 | 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer | completed | Phase 3 | 856 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00814125 | ATAC - Endometrial Sub-Protocol | completed | Phase 3 | 285 | AstraZenecaINDUSTRY | 0 | May 1, 2009 | clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00234403 | A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Dec 23, 2009source: clinicaltrials